Janus Labs raises pre-seed round led by New York Angels for pet brain sensing
Janus Labs AI, which builds contactless brain sensing for dogs and cats, raised a $1.8M pre-seed led by New York Angels, with Kinisis Ventures joining.

Janus Labs AI, a U.S. startup building contactless brain sensing for dogs and cats, has raised a $1.8M pre-seed round led by New York Angels. Harvard Business School Alumni Angels of Greater New York, SkyRiver Ventures and Cyprus-based Kinisis Ventures also took part, according to Cyprus Mail.
The round brings Janus's total raised to $2.6M. The company says its patented system measures brain activity without physical contact. It combines that data with physiological readings to build a profile of each animal.
Its AI then looks for early changes in physical and mental wellbeing and recommends personalized care and enrichment activities.
Investors back Janus's neural profile approach
Peter Freer founded the New York company, which lists its address at 7 Pennsylvania Plaza, and Shaun Westbrook is co-founder and chief executive. Its SOSV profile lists it as a pre-seed company in the IndieBio New York program, and Cyprus Mail reports it completed the SOSV NY/IndieBio accelerator.
Janus won Best Product at The Ventures Startup Awards during NY Tech Week 2026 and placed in the top 10 at the SF Tech Week Consumer AI Pitch Fest. It reports nine U.S. patents, five published human studies and clinical validation across multiple dog breeds.
"We're not interested in building another pet tracker," said Westbrook. He added that "Janus provides the closest thing to being able to have a conversation with your pet, with profound implications for your pet's health, quality of life and wellbeing."
Tom Hirschfeld represents New York Angels and the HBS Alumni Angels group. He said his experience as an early investor in companies including Loyal Animal Health gave him the chance to reconsider approaches to animal health and longevity.
"Janus brings a valuable new dimension to that progress," Hirschfeld said.
SkyRiver general partner Hyuk-Jeen Suh, who founded and formerly headed Samsung Ventures' East Coast office, said he sees "strong potential in its proprietary technology and ability to create an entirely new consumer health category." New York Angels also lists Janus Labs under Healthcare on its portfolio page.
Collars already sell health monitoring to owners
Janus enters a market where health claims already sit on the collar. Fi's Ultra tracker, covered in our Fi Ultra report, carries a $189 annual membership, and Fi's own site pairs GPS with AI-powered health monitoring.
Tractive lists resting heart rate and respiratory rate among the vitals it monitors. Bending Spoons closed its purchase of the company on May 18th, 2026. PetPace's collar tracks temperature, pulse and respiration, and it went on sale at Chewy for $299.99 in a launch we covered.
For collar makers such as Fi, Tractive and PetPace, Janus adds brain activity to the vitals and location data they already sell to dog and cat owners. For early-stage investors, it is a pre-seed entry in pet health hardware and AI, with Kinisis as the Cyprus-based fund in a round led from New York.
Kinisis co-founder Andreas Panayi said that "Janus Labs is going after something genuinely different in a pet-tech market that has grown crowded with activity trackers."
Freer's name is on non-contact brain sensing patents
Peter Freer is a named inventor on US 11,517,240, filed April 26th, 2017 and granted December 6th, 2022. He is also named on US 10,694,946, granted June 30th, 2020.
Google Patents lists Freer Logic Inc as assignee on both, and both describe non-contact sensors that pick up a person's brain electrical activity.
Janus says the new money goes into its dog and cat monitoring technology. Longer term, it aims to close the communication gap between people and animals.
Source: Cyprus Mail
Other News
More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.
